Literature DB >> 30088132

Candidate Tumor Suppressor Gene EAF2 is Mutated in Colorectal and Gastric Cancers.

Yun Sol Jo1, Sung Soo Kim2, Min Sung Kim1, Nam Jin Yoo1, Sug Hyung Lee3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30088132     DOI： 10.1007/s12253-018-0461-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  5 in total

1.  Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers.

Authors:  Hye Rim Oh; Chang Hyeok An; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2015-01-09       Impact factor: 3.201

2.  ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.

Authors:  Federico Simone; Roger T Luo; Paul E Polak; Joseph J Kaberlein; Michael J Thirman
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

Review 3.  Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.

Authors:  Kohzoh Imai; Hiroyuki Yamamoto
Journal:  Carcinogenesis       Date:  2007-10-17       Impact factor: 4.944

4.  Eaf1 and Eaf2 negatively regulate canonical Wnt/β-catenin signaling.

Authors:  Jing-Xia Liu; Dawei Zhang; Xunwei Xie; Gang Ouyang; Xing Liu; Yonghua Sun; Wuhan Xiao
Journal:  Development       Date:  2013-01-30       Impact factor: 6.868

5.  Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer.

Authors:  Wuhan Xiao; Qiuheng Zhang; Feng Jiang; Michael Pins; James M Kozlowski; Zhou Wang
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.